News
Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...
As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
Novo Nordisk said on Thursday it is offering self-paying patients who are new to its weight loss drug Wegovy their first ...
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Explore more
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results